Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 475, pseudogene (RN7SL475P) is a pseudogene located in the human genome that exhibits sequence homology to 7SL RNA, a critical non-coding RNA component of the signal recognition particle (SRP)[6][5][3]. The canonical 7SL RNA plays an essential role in guiding nascent protein chains to the endoplasmic reticulum during translation by forming the core of the SRP complex[1]. However, RN7SL475P, like most 7SL RNA-derived pseudogenes, is considered a non-functional, non-protein-coding remnant that results from retrotransposition or genomic rearrangement events which have rendered it transcriptionally inactive or otherwise non-functional[3][5][7]. There is no evidence to suggest that RN7SL475P serves a direct biological function, acts as a therapeutic target, or is involved in clinically actionable disease processes[2][6]. 7SL pseudogenes might have roles as non-functional genomic elements, and there is ongoing research into possible regulatory or competitive endogenous RNA (ceRNA) activity for certain pseudogenes, but no such evidence directly exists for RN7SL475P[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 475, pseudogene (RN7SL475P).